Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients
Jennifer Cautela, Jean‐Michel Tartière, Alain Cohen‐Solal, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 8, pp. 1357-1365
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
European Heart Journal (2021) Vol. 42, Iss. 36, pp. 3599-3726
Open Access | Times Cited: 8803
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa McDonagh, Marco Metra, Marianna Adamo, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 1, pp. 4-131
Open Access | Times Cited: 1537
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
Revista Española de Cardiología (2022) Vol. 75, Iss. 6, pp. 523.e1-523.e114
Closed Access | Times Cited: 89
Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC
Marco Metra, Marianna Adamo, Daniela Tomasoni, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 1115-1131
Open Access | Times Cited: 43
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC
Gianluigi Savarese, Felix Lindberg, Antonio Cannatà, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1278-1297
Open Access | Times Cited: 17
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC
Hadi Skouri, Nicolas Girerd, Luca Monzo, et al.
European Journal of Heart Failure (2025)
Closed Access | Times Cited: 2
Practical outpatient management of worsening chronic heart failure
Nicolas Girerd, Nathan Mewton, Jean‐Michel Tartière, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 5, pp. 750-761
Open Access | Times Cited: 43
Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
Nicolas Girerd, Jean‐Jacques Von Hunolstein, Pierpaolo Pellicori, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 4, pp. 2063-2069
Open Access | Times Cited: 40
Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts
Nicolas Girerd, Christophe Leclercq, Olivier Hanon, et al.
Revista Española de Cardiología (English Edition) (2023) Vol. 76, Iss. 10, pp. 813-820
Open Access | Times Cited: 31
Physician perceptions, attitudes, and strategies towards implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice
Gianluigi Savarese, Felix Lindberg, Ruxandra Christodorescu, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1408-1418
Open Access | Times Cited: 12
Intra-Aortic Balloon Pumping in Acute Decompensated Heart Failure With Hypoperfusion: From Pathophysiology to Clinical Practice
Luca Baldetti, Matteo Pagnesi, Mario Gramegna, et al.
Circulation Heart Failure (2021) Vol. 14, Iss. 11
Open Access | Times Cited: 44
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial
Marco Metra, Matteo Pagnesi, Brian Claggett, et al.
European Heart Journal (2022) Vol. 43, Iss. 48, pp. 5006-5016
Open Access | Times Cited: 29
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
Michael E. Dunn, Aaron Kithcart, Jee Hae Kim, et al.
Nature (2024) Vol. 633, Iss. 8030, pp. 654-661
Open Access | Times Cited: 7
Blood pressure and intensive treatment up‐titration after acute heart failure hospitalization: Insights from the STRONG‐HF trial
Matteo Pagnesi, Oscar A. Gomez Vilamajo, Alejandro Meiriño, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 3, pp. 638-651
Closed Access | Times Cited: 6
Hypertension and Heart Failure: From Pathophysiology to Treatment
Giovanna Gallo, Carmine Savoia
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6661-6661
Open Access | Times Cited: 6
Impact of Cardiovascular Hemodynamics on Cognitive Aging
Elizabeth E. Moore, Angela L. Jefferson
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 4, pp. 1255-1264
Open Access | Times Cited: 28
Detailed Assessment of the “I Need Help” Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry
Matteo Pagnesi, Daniele Ghiraldin, Enrico Vizzardi, et al.
Circulation Heart Failure (2023) Vol. 16, Iss. 12
Closed Access | Times Cited: 12
Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction in PARADIGM-HF
Shingo Matsumoto, Li Shen, Alasdair Henderson, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 18, pp. 1685-1700
Closed Access | Times Cited: 4
Dialysis Transition Patterns of Chronic Kidney Disease Patients With and Without Heart Failure
Mitchell Flagg, Simran K. Bhandari, Katherine J. Pak, et al.
Mayo Clinic Proceedings (2025)
Open Access
Low blood pressure and the effect of empagliflozin in acute heart failure: An EMPULSE analysis
João Pedro Ferreira, Francisco Vasques‐Nóvoa, Christiane E. Angermann, et al.
European Journal of Heart Failure (2025)
Closed Access
Prognostic implication of outpatient loop diuretic dose intensification trajectories in patients with chronic heart failure
Toshiharu Koike, Atsushi Suzuki, Noriko Kikuchi, et al.
IJC Heart & Vasculature (2025) Vol. 57, pp. 101632-101632
Open Access
Novel Small-Molecule Troponin Activator Increases Cardiac Contractile Function Without Negative Impact on Energetics
Huamei He, Tomáš Baka, James A. Balschi, et al.
Circulation Heart Failure (2021) Vol. 15, Iss. 3
Open Access | Times Cited: 25
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure
Matteo Pagnesi, Marianna Adamo, Iziah E Sama, et al.
Clinical Research in Cardiology (2022) Vol. 111, Iss. 8, pp. 912-923
Open Access | Times Cited: 18
The treatment with sGC stimulator improves survival of hypertensive rats in response to volume-overload induced by aorto-caval fistula
Olga Gawryś, Zuzana Husková, Petra Škaroupková, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 12, pp. 3757-3773
Open Access | Times Cited: 10
Hypotension in heart failure is less harmful if associated with high or increasing doses of heart failure medication: Insights from the Swedish Heart Failure Registry
Nicolas Girerd, Stefano Coiro, Lina Benson, et al.
European Journal of Heart Failure (2023) Vol. 26, Iss. 2, pp. 359-369
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top